Publications
31
Citations
907
Est. group size
~10
Recurring co-author estimate
Active years
15
Publishing since 2012
Ann-Kathrin Eisfeld's research focuses on the biology and treatment of acute myeloid leukemia (AML) and related blood cancers, including how specific genetic changes affect disease behavior and response to therapy. Recent work has examined combination drug treatments targeting cell survival pathways and cancer cell growth machinery in AML subtypes defined by particular gene duplications. This research is aimed at understanding leukemia at a molecular level to inform more precise treatment strategies.
Publication output was minimal or absent from 2017-2019 and 2022-2023, but has increased notably since 2024, suggesting a recent growth phase in research activity.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Blood×12
- Blood Advances×4
- bioRxiv (Cold Spring Harbor Laboratory)×2
- Journal of Hematology & Oncology×1
- Transplantation and Cellular Therapy×1
- Helee Desai
Medicine · The Ohio State University
- Jessica Kohlschmidt
Medicine · The Ohio State University
- Deedra Nicolet
Medicine · The Ohio State University
- Krzysztof Mrózek
Medicine · The Ohio State University
- Alice S. Mims
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile